Financials
- Market Capitalization 2.08 B
- Employee 398
- Founded 1989
- CEO Nick Colangelo
- Website www.vcel.com
- Headquarter Michigan, United States
- FIGI BBG000BDCM24
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
112.53
売上高対価格比率
6.8
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 1911 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.92 USD | -2.24% | -14.97% | +22.50% | -26.18% | 2.10 B USD | ||
| 1927 | VRDN Viridian Therapeutics, Inc. - Common Stock | 18.16 USD | -0.77% | -3.25% | -15.42% | -19.11% | 2.06 B USD | ||
| 1944 | IMNM Immunome, Inc. - Common Stock | 17.63 USD | -7.94% | -13.15% | -28.04% | +27.75% | 2.00 B USD | ||
| 1949 | FTRE Fortrea Holdings Inc. - Common Stock | 20.97 USD | -0.14% | -4.03% | +21.78% | +121.67% | 1.99 B USD |